$EFX

Equifax Shares Rise After Argus Research Upgrade

Equifax shares rose after Argus Research upgraded the company to 'Buy' with a $200 price target. The stock gained 6.23% on the day and 15.90% year-to-date, though it is down 13.86% over 5 days. The upgrade was based on a weighted average of various ratings, including valuation and EPS revisions.

Original reporting
Published Oct 22, 2026, 6:51 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 22, 2026, 7:04 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefMarket movers
Primary signal
$EFX
Bullish
high confidence
Mentioned
$EFX
Relevance
7/10
AlphAI data visualization · based on marketscreener.com
Decision brief

The 30-second read

$EFXBullishMed
01

Why it matters

The upgrade adds a fresh bullish catalyst, likely attracting short‑term buying.

02

Market read

Equifax shares rose sharply on the upgrade, indicating immediate market reaction.

03

What to watch

Potential regulatory scrutiny of credit bureaus could temper upside.

Relevance 7/10Novelty 6/10Timing: pre‑market today

Background

Equifax (EFX) is a major U.S. consumer credit reporting agency; analyst upgrades can move the stock.

Company-level read

Ticker impact

$EFXBullishHigh confidence
Context

Equifax received an Argus Research upgrade to Buy with a $200 price target, prompting a 6.23% share rise.

Expected impact

upward pressure as traders price in the new buy rating and $200 target

Evidence & confidence

Analyst upgrade with explicit price target is a fresh catalyst that typically lifts the stock.

Market effects

Credit reporting sector may see modest uplift as the upgrade signals improved outlook for consumer data services.

U.S. markets may see a small positive bias in financial services stocks.

Limited to U.S. equities; no broader global effect.

Counterpoint

The upgrade may be premature if underlying credit risk metrics remain unchanged.

Key entities

  • Equifax

    U.S. credit reporting firm

  • Argus Research

    Equity research firm issuing the upgrade

Related articles

$EFXMed

Why Equifax (EFX) stock is trading up today

Equifax (EFX) stock rose 6.3% after Argus upgraded it to Buy with a $200 target, citing growth and a dividend increase. Q3 earnings beat estimates at $2.26 per share, with revenue up 9.6% to $1.69B. The stock is down 12.6% YTD and 20% below its 52-week high.

$SMCIHighAI 8/10

US Stocks Mixed as Super Micro, Equifax, Hasbro Jump

Super Micro (SMCI) rose 9.67% on stronger-than-expected revenue outlook, projecting $18.5B-$19.5B for Q1. Hasbro (HAS) gained 1.26% after Q3 earnings beat estimates by 55.91%. Equifax (EFX) surged 10.7% on Q3 results, despite lowering full-year revenue guidance. AT&T (T) shares fell 5.96% despite raising 2026 earnings guidance.

$EFXMedAI 8/10

UBS reiterates Buy on Equifax stock, keeps $220 price target

UBS maintained a Buy rating on Equifax (NYSE:EFX) with a $220 price target, citing strong Q3 earnings and an upbeat outlook. The stock is currently at $174.53, with InvestingPro valuing it at $228.97. Equifax's government business grew to $550M in annual contract value, and its records increased 12% YoY. Analysts have mixed views on its performance, with targets ranging from $175 to $217.

$SPCXHighAI 8/10

Watch SpaceX, Netflix, Equifax, and More

SpaceX (SPCX) stock rose 8% after-hours on strong Q3 results: $14.6B revenue (+161% Y/Y), $0.35 EPS beat. Growth driven by AI, Connectivity, and Space units. Netflix (NFLX) fell 5.8% post-earnings, with $12.87B revenue (+11.8% Y/Y) and $0.87 EPS. Q4 revenue forecast at $51.1B (13% Y/Y).